Why Health Catalyst, Inc.’s (HCAT) Stock Is Down 5.29%
As of Wednesday, September 23, Health Catalyst, Inc.’s HCAT share price has dipped by 5.29%, which has investors questioning if this is right time to buy.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics. The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, accountable care organizations, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.
Commentary & Analysis
Why Health Catalyst, Inc.’s (HCAT) Stock Is Up 7.14%
As of Friday, August 14, Health Catalyst, Inc.’s HCAT share price has surged by 7.14%, which has investors questioning if this is right time to sell.Jenna Brashear
Why Health Catalyst, Inc.’s (HCAT) Stock Is Down 27.06%
As of Friday, August 07, Health Catalyst, Inc.’s HCAT share price has dipped by 27.06%, which has investors questioning if this is right time to buy.Michael Rose
Why Health Catalyst, Inc.’s (HCAT) Stock Is Down 25.97%
As of Friday, August 07, Health Catalyst, Inc.’s HCAT share price has dipped by 25.97%, which has investors questioning if this is right time to buy.Tudor Pop
Why Health Catalyst, Inc.’s (HCAT) Stock Is Down 5.65%
As of Thursday, August 06, Health Catalyst, Inc.’s HCAT share price has dipped by 5.65%, which has investors questioning if this is right time to buy.Michael Rose
Financial Summary
| Share Statistics | HCAT | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $131.7 | $168.2 | 24% |
|
| Shares Out (Mil) | 74.0 | 42.5 | 56% |
|
| Institutional Ownership | 91.9% | 78.4% | 60% |
|
| Float (Mil) | 59.3 | 38.7 | 51% |
|
| Beta | 1.53 | 1.17 | 83% |
|
| Avg Daily Volume (000s) | 493 | 243 | 58% |
|
| Price Change (52-week) |
(42.6%) | 47.9% | 23% |
|
| Growth | HCAT | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 10.5% | 11.8% | 60% |
|
| Net Income (5yr) | (9.1%) | 2.7% | 30% |
|
| EPS (5yr) | 2.6% | 15.5% | 35 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (28.6%) | (15.8%) | 21% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 4 | 4 | 4 | |
| Current EPS | ($0.048) | ($0.035) | $0.008 | |
| Month Ago EPS | ($0.054) | ($0.045) | $0.008 | |
| # Rev Up | 1 | 0 | 1 | |
| # Rev Down | 1 | 1 | 4 | |
| Three Months Ago EPS | $0.000 | $0.042 | $0.092 | |
| Year/Year Chg | (91.2%) | (98.6%) | (105.1%) | |
| Financials | HCAT | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $292 | $202 | 35% |
|
| Net Income (TTM) (Mil) | ($265) | ($9) | 5% |
|
| EPS (TTM) | ($3.679) | ($1.000) | 10% |
|
| Operating Cash Flow (TTM) (Mil) | $28 | ($1) | 43% |
|
| Net Cash Flow (TTM) (Mil) | $10 | $3 | 56% |
|
| Long-Term Debt (Q1) (Mil) | $165 | $18 | 48% |
|
| Enterprise Value (Q1) (Mil) | $201 | $160 | 26% |
|
| Valuation | HCAT | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.30 | 1.29 | 36% |
|
| P/E | na | 44.0 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 2.9 | na |
|
| Ratios | HCAT | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 51.2% | 60.9% | 63% |
|
| Net Margin | (90.6%) | (26.3%) | 8% |
|
| ROA | (54.3%) | (22.8%) | 11% |
|
| ROE | (118.1%) | (9.8%) | 8% |
|
| Liabilities to Assets | 71.9% | 33.3% | 67% |
|
| F-Score | 5 | 4 | 50% |
|
Health Catalyst, Inc. did not pass any screens on 10/20/2026.
